clofibrate has been researched along with aspirin in 109 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 86 (78.90) | 18.7374 |
1990's | 6 (5.50) | 18.2507 |
2000's | 6 (5.50) | 29.6817 |
2010's | 11 (10.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsumoto, K; Mori, T; Moriya, T; Odawara, A; Seki, M; Takabe, S; Takashima, K; Takeyama, S | 1 |
Strassburg, CP; Tukey, RH | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Chuang, S; Horne, J; Porter, CJ; Scanlon, MJ; Velkov, T | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Haft, JI | 1 |
Gotoh, M; Griffin, C; Hruban, Z | 1 |
Gustafsson, BE; Norin, KE | 1 |
Mustard, JF; Packham, MA | 1 |
Verstraete, M | 6 |
Bokarev, IN; Komarov, FI; Liusov, VA | 1 |
Weiss, HJ | 3 |
Hirsh, J; Turpie, AG | 1 |
Clagett, GP; Collins, GJ | 1 |
Genton, E | 1 |
Zicot, M | 1 |
Yasunaga, K | 1 |
Gryglik, J | 1 |
Salvadori, G; Zannino, L | 1 |
Caen, JP; Wautier, JL | 1 |
Hirsh, J | 2 |
Dettori, AG; Pini, M; Quintavalla, R | 1 |
Latour, JG | 1 |
Gantmacher, ML | 1 |
Mehta, J; Mehta, P | 1 |
Ciammaichella, A | 1 |
Hladovec, J | 2 |
Ishii, H; Suga, T | 1 |
Dechavanne, M; Follea, G; Trzeciak, MC | 1 |
Blakely, JA | 1 |
Inoue, M; Morikawa, M; Sugiura, M; Tsuboi, M | 1 |
Ardlie, NG | 1 |
Bruseghini, L; Vilageliu, J | 1 |
Gent, M; Genton, E; Harker, LA; Hirsh, J | 4 |
Gallus, AS; Hirsh, J | 1 |
Aledort, LM | 1 |
Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 1 |
Gent, M; Genton, E; Hirsh, J | 1 |
Vermylen, J | 1 |
Keller, BJ; Thurman, RG; Yamanaka, H | 1 |
Boiteux-Antoine, AF; Fournel-Gigleux, S; Knehr, M; Magdalou, J; Oesch, F; Post, K; Schladt, L; Siest, G; Thomas, H | 1 |
Brady, LJ; Brady, PS; Marine, KA; Ramsay, RR | 1 |
Borhani, NO | 1 |
Bird, HA; Dixon, JS; Wright, V | 1 |
Dostert, P; Hartmann, R; Oesch, F; Schladt, L; Strolin-Benedetti, M; Timms, C; Wörner, W | 1 |
Brady, LJ; Brady, PS | 1 |
O'Reilly, RA | 1 |
Ishihara, N; Kojima, S; Nakagawa, M; Shimokawa, T | 1 |
Oesch, F; Schladt, L | 1 |
Berge, KG; Canner, PL; Friedewald, W; Friedman, L; Prineas, RJ; Stamler, J; Wenger, NK | 1 |
Hucker, HB; Stauffer, SC; White, SE | 1 |
Azarnoff, DL; Svoboda, DJ | 1 |
Flower, R; Gryglewski, R; Herbaczyńska-Cedro, K; Vane, JR | 1 |
Vargaftig, BB; Zirinis, P | 1 |
Bouvier, CA | 1 |
Chou, SF; Gotoh, M; Hruban, Z; Slesers, A | 1 |
Pantaleoni, GC; Valeri, P | 1 |
La Du, B | 1 |
Besançon, F; Marche, C | 1 |
Barret, C; Besançon, F; Marche, C; Parrot, J | 1 |
Marshall, AJ | 1 |
Furuta, S; Hashimoto, T; Miyazawa, S | 1 |
Bousser, MG | 2 |
Stamler, J | 1 |
Bertha, G; Lechner, H; Ott, E | 1 |
Ramirez-Lassepas, M | 1 |
Díez, MM; Fernández, A; Gil, M; Lasierra, J; Velázquez, E; Viladés, E | 1 |
Heymann, E; Mentlein, R | 1 |
Hirose, A; Kawashima, Y; Kozuka, H | 1 |
O'Brien, JR | 1 |
Dingle, JT; Hazleman, B; Pilsworth, LM; Sheppeard, H | 1 |
Birgens, HS; Hansen, MS | 1 |
Loogen, F; Misera, R; Reimers, HJ; Schneider, W | 1 |
Cristol, R | 1 |
Turpie, AG | 1 |
Bruseghini, L; Dalmau, J; Vicens, B; Zapatero, J | 1 |
Paredero Del Bosque Martin, V | 1 |
Croveri, G | 1 |
Appelkvist, EL; Cai, Y; DePierre, JW | 1 |
Gil, MJ; Monreal, JI; Rivero, A | 1 |
Cai, Y; dePierre, JW; Li, R; Luciakova, K; Nelson, BD | 1 |
Becedas, L; Bengtsson Ahlberg, M; Georgellis, A; Lundqvist, G; Mehrotra, K; Morgenstern, R | 1 |
Dallner, G; Sindelar, P; Turunen, M | 1 |
Dragomir, E; Manduteanu, I; Simionescu, M; Tircol, M; Voinea, M | 1 |
38 review(s) available for clofibrate and aspirin
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
[Indications and uncertainties of antiaggregating agents].
Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1978 |
Platelets, thromboembolism and the clinical utility of antiplatelet drugs.
Topics: Animals; Aspirin; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Clofibrate; Fibrinolytic Agents; Humans; Platelet Aggregation; Rabbits; Thromboembolism | 1978 |
Cardiac thromboembolism: evidence for role of platelets and value of platelet suppressant therapy.
Topics: Aspirin; Blood Platelets; Cell Survival; Clofibrate; Coronary Disease; Heart Diseases; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Thromboembolism | 1978 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agents; Humans; Pentoxifylline; Snake Venoms; Xanthinol Niacinate | 1979 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
[Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease].
Topics: Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Platelet Aggregation | 1979 |
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type 1; Dipyridamole; Glomerulonephritis; Hemolytic-Uremic Syndrome; Heparin; Humans; Hyperlipidemias; Platelet Aggregation; Polycythemia Vera; Prostaglandins E | 1979 |
Pharmacology of platelet-suppressive agents.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents; Arachidonic Acids; Aspirin; Blood Platelets; Calcium; Cell Membrane; Clofibrate; Dipyridamole; Epoprostenol; Halofenate; Heparin; Humans; Imidazoles; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins E; Prostaglandins, Synthetic | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
[Clinical prevention of thrombosis by antiplatelet agents].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombosis | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Male; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemia; Kidney Diseases; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Serotonin Antagonists; Sulfinpyrazone; Sympathomimetics; Thrombosis | 1976 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibrinolytic Agents; Humans; Hydroxychloroquine; Myocardial Infarction; Plasminogen Activators; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1976 |
Are agents affecting platelet functions clinically useful?
Topics: Aged; Animals; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Dogs; Heparin; Humans; Male; Platelet Aggregation; Thromboembolism; Thrombophlebitis; Thrombosis | 1976 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Graft Rejection; Heart Valve Prosthesis; Hemostasis; Humans; Kidney Transplantation; Myocardial Infarction; Platelet Aggregation; Serotonin Antagonists; Thromboembolism; Thrombosis; Transplantation, Homologous | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Warfarin metabolism and drug-drug interactions.
Topics: Anti-Bacterial Agents; Aspirin; Barbiturates; Cholestyramine Resin; Clofibrate; Diuretics; Drug Interactions; Ethanol; Humans; Rifampin; Vitamin K; Warfarin | 1987 |
[Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
Topics: Adult; Aspirin; Blood Platelets; Child; Clofibrate; Dextrans; Dipyridamole; Drug Combinations; Graft Rejection; Heart Valve Prosthesis; Humans; Platelet Adhesiveness; Platelet Aggregation; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
Plasma esterase activity and the metabolism of drugs with ester groups.
Topics: Aspirin; Cholinesterase Inhibitors; Cholinesterases; Chromatography, Gel; Clofibrate; Electrophoresis; Esterases; Esters; Genetics, Medical; Humans; Isoenzymes; Kinetics; Models, Biological; Pharmacogenetics; Phenylacetates; Receptors, Cholinergic; Succinylcholine; Tromethamine | 1971 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Diuretics; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Sulfinpyrazone | 1981 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggregation; Erythrocytes; Humans; Ischemic Attack, Transient; Pentoxifylline; Plasma; Platelet Aggregation; Sulfinpyrazone | 1983 |
Platelet inhibitors for TIAs. A review of prospective drug trial results.
Topics: Aged; Aspirin; Clofibrate; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation; Prospective Studies; Recurrence; Sulfinpyrazone | 1984 |
Hypothesis: polypharmacy. The treatment of thrombotic risk.
Topics: Aspirin; Blood Coagulation Tests; Clofibrate; Hemorrhage; Heparin; Humans; Thrombosis; Warfarin | 1980 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Humans; Kidney Diseases; Sulfinpyrazone; Thrombosis | 1980 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Humans; Hydroxychloroquine; Lidocaine; Platelet Aggregation; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Heart Valve Diseases; Humans; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1981 |
17 trial(s) available for clofibrate and aspirin
Article | Year |
---|---|
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
[Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
Topics: Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Evaluation; Hemostasis; Humans; Pentoxifylline; Phenothiazines; Piperazines; Pyridinolcarbamate | 1978 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrans; Female; Heart Valve Prosthesis; Hemostasis; Humans; Male; Microcirculation; Middle Aged; Postoperative Complications; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Survival; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Myocardial Infarction; Postoperative Complications; Renal Dialysis; Sulfinpyrazone; Thrombocytosis; Thromboembolism | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Hydroxychloroquine; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1975 |
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.
Topics: Adult; Aspirin; Clofibrate; Dextrothyroxine; Estrogens; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Niacin; Time Factors | 1986 |
[Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Topics: Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Sulfinpyrazone | 1983 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
[Platelets and coronary artery disease (CAD) (author's transl)].
Topics: Animals; Aspirin; Autopsy; Blood Platelets; Cardiomyopathies; Cell Wall; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Heparin Antagonists; Humans; Platelet Aggregation; Risk; Sulfinpyrazone | 1980 |
Plafibride tolerance trial in healthy volunteers.
Topics: Adult; Aspirin; Clofibrate; Clofibric Acid; Double-Blind Method; Erythrocyte Count; Humans; Hypolipidemic Agents; Leukocyte Count; Lipids; Platelet Aggregation | 1981 |
62 other study(ies) available for clofibrate and aspirin
Article | Year |
---|---|
Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds.
Topics: Animals; Cholesterol; Hypolipidemic Agents; Male; Oxazoles; Platelet Aggregation; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Triglycerides | 1988 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Characterization of the drug binding specificity of rat liver fatty acid binding protein.
Topics: Anilino Naphthalenesulfonates; Animals; Fatty Acid-Binding Proteins; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Fluorescence; Substrate Specificity | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effect of citrate and aminotriazole on matrical plates induced in hepatic microbodies.
Topics: Amitrole; Animals; Aspirin; Body Weight; Carboxylic Acids; Catalase; Citrates; Clofibrate; Cyclopropanes; Esters; Inclusion Bodies; Ketoglutaric Acids; Liver; Methylation; Microbodies; Organ Size; Organoids; Propionates; Rats; Triazoles | 1975 |
Development of germfree animal characteristics in conventional rats in antibiotics.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aspirin; Bacitracin; Bile Pigments; Cholestanol; Clofibrate; Colistin; Erythromycin; Feces; Ferrous Compounds; Germ-Free Life; Intestines; Kanamycin; Male; Metronidazole; Neomycin; Oxytetracycline; Penicillin G; Rats; Sorbitol; Sulfathiazoles; Tetracycline | 1977 |
Status of antiplatelet drugs in coronary heart disease.
Topics: Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Male; Models, Biological; Platelet Aggregation; Propranolol; Sulfinpyrazone | 1979 |
[Current status of vascular diseases and their treatment].
Topics: Arteriosclerosis; Aspirin; Clofibrate; Humans; Indomethacin; Sulfinpyrazone; Vasodilator Agents | 1979 |
Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
Topics: Animals; Aspirin; Citrates; Clofibrate; Dipyridamole; Endothelium; Female; Hydroxychloroquine; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
Clofibrate-like effects of acetylsalicylic acid on peroxisomes and on hepatic and serum triglyceride levels.
Topics: Animals; Aspirin; Catalase; Clofibrate; Liver; Male; Microbodies; Organoids; Rats; Subcellular Fractions; Triglycerides; Urate Oxidase | 1979 |
[Antiplatelet drugs (author's transl)].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Female; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Myocardial Infarction; Nicergoline; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
Vasotropic drugs--a survey based on a unifying concept of their mechanism of action.
Topics: Animals; Aspirin; Blood Vessels; Calcium Dobesilate; Clofibrate; Coumarins; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavonoids; Glycosides; Pyrithioxin; Rats; Rutin; Vasomotor System | 1977 |
Platelet suppressing drugs in arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Humans; Myocardial Infarction; Sulfinpyrazone; Vascular Diseases | 1978 |
Species difference and characterization of intestinal esterase on the hydrolizing activity of ester-type drugs.
Topics: Animals; Aspirin; Carbenicillin; Clofibrate; Diet; Dogs; Esterases; Esters; Guinea Pigs; Humans; Hydrolysis; In Vitro Techniques; Intestinal Mucosa; Intestines; Male; Mice; Rabbits; Rats; Species Specificity; Subcellular Fractions | 1979 |
Antiplatelet therapy (first of two parts).
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Clofibrate; Dextrans; Dipyridamole; Heparin; Humans; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
Antiplatelet agents in coronary disease: are they of prophylactic value?
Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1978 |
Investigation of the role of arachidonic acid in platelet function and mechanisms for suppression of prostaglandin biosynthesis.
Topics: Arachidonic Acids; Aspirin; Blood Platelets; Clofibrate; Halofenate; Hypolipidemic Agents; Malondialdehyde; Prostaglandins; Serotonin | 1978 |
[ITA 104, a product of antiplatelet aggregation activity].
Topics: Adenosine Diphosphate; Animals; Aspirin; Clofibrate; Clofibric Acid; Depression, Chemical; Dogs; Platelet Aggregation; Rats | 1978 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1977 |
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone | 1976 |
Clinical pharmacology of anti-aggregating substances.
Topics: Aspirin; Clofibrate; Dextrans; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1975 |
Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents.
Topics: Animals; Aspirin; Cell Division; Clofibrate; Clofibric Acid; Dose-Response Relationship, Drug; Female; Fibric Acids; Hypolipidemic Agents; L-Lactate Dehydrogenase; Microbodies; Mitochondria, Liver; Oxygen Consumption; Rats; Rats, Inbred Strains; Trypan Blue; Valproic Acid | 1992 |
Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
Topics: Animals; Aspirin; Clofibrate; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Cytosol; Epoxide Hydrolases; Fatty Alcohols; Glucuronosyltransferase; Glutathione Transferase; Guinea Pigs; Hypolipidemic Agents; Imidazoles; Male; Microbodies; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Inbred F344 | 1989 |
Co-ordinate induction of hepatic mitochondrial and peroxisomal carnitine acyltransferase synthesis by diet and drugs.
Topics: Acyltransferases; Animals; Aspirin; Carnitine Acyltransferases; Carnitine O-Palmitoyltransferase; Clofibrate; Dietary Fats; Diethylhexyl Phthalate; Liver; Male; Microbodies; Mitochondria, Liver; Rats; Rats, Inbred Strains | 1989 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone | 1985 |
Therapeutic significance of laboratory results in rheumatic disease.
Topics: Anti-Inflammatory Agents; Arthritis, Reactive; Aspirin; Blood Viscosity; C-Reactive Protein; Captopril; Ceruloplasmin; Clofibrate; Gene Frequency; Gold Sodium Thiomalate; Histidine; HLA Antigens; HLA-B27 Antigen; Humans; Hydroxychloroquine; Phenylacetates; Rheumatic Diseases; Spondylitis; Spondylitis, Ankylosing; Sulfhydryl Compounds; Uveitis | 1985 |
Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
Topics: Animals; Aspirin; Clofibrate; Cytosol; Dose-Response Relationship, Drug; Enzyme Induction; Epoxide Hydrolases; Fatty Alcohols; Fenofibrate; Hepatomegaly; Hypolipidemic Agents; Imidazoles; Liver; Male; Microbodies; Microsomes, Liver; Oxidation-Reduction; Palmitoyl-CoA Hydrolase; Probucol; Rats; Rats, Inbred F344 | 1987 |
Effects of clofibrate and acetylsalicylic acid on hepatic carnitine palmitoyltransferase synthesis.
Topics: Acyltransferases; Animals; Aspirin; Carnitine O-Palmitoyltransferase; Clofibrate; Diethylhexyl Phthalate; Glucagon; Liver; Male; Rats; Rats, Inbred Strains; RNA, Messenger; Transcription, Genetic | 1989 |
Effect of clofibrate on lipid peroxidation in rats treated with aspirin and 4-pentenoic acid.
Topics: Animals; Aspirin; Clofibrate; Cytosol; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Lipid Metabolism; Lipid Peroxides; Liver; Male; Microsomes, Liver; Mitochondria, Liver; Proteins; Rats; Rats, Inbred Strains; Salicylates; Salicylic Acid; Sulfhydryl Compounds | 1987 |
Coordinate induction of peroxisomal beta-oxidation activity and cytosolic epoxide hydrolase activity.
Topics: Animals; Aspirin; Benzimidazoles; Clofibrate; Cytosol; Enzyme Induction; Epoxide Hydrolases; Fatty Alcohols; Hypolipidemic Agents; Male; Microbodies; Oxidation-Reduction; Rats; Rats, Inbred F344; Rats, Inbred Strains; Species Specificity; Temperature | 1987 |
Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys.
Topics: Acetamides; Animals; Anticholesteremic Agents; Antipyrine; Aspirin; Blood Proteins; Carbon Isotopes; Chlorothiazide; Clofibrate; Dicumarol; Digitoxin; Drug Interactions; Fluorine; Glycolates; Half-Life; Haplorhini; Humans; Hypolipidemic Agents; Indomethacin; Macaca; Phenothiazines; Phenylbutazone; Salicylates; Warfarin | 1972 |
Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
Topics: 2,4-Dichlorophenoxyacetic Acid; Animals; Anticholesteremic Agents; Aspirin; Blood Proteins; Catalase; Clofibrate; D-Amino-Acid Oxidase; Hypolipidemic Agents; Lipids; Liver; Male; Mitochondria, Liver; Organoids; Oxidoreductases; Propionates; Protein Binding; Rats; Thyroxine; Valerates | 1969 |
Effects of anti-inflammatory drugs on prostaglandin biosynthesis.
Topics: Acetaminophen; Aldosterone; Animals; Anti-Inflammatory Agents; Aspirin; Azathioprine; Benzoates; Biological Assay; Clofibrate; Dexamethasone; Dogs; Edema; Fludrocortisone; Hydrocortisone; In Vitro Techniques; Indomethacin; Mefenamic Acid; Oxygenases; Phenylbutazone; Prostaglandins; Rats; Spleen; Triamcinolone Acetonide | 1972 |
Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2.
Topics: Acetaminophen; Anti-Inflammatory Agents; Aorta; Arachidonic Acids; Aspirin; Biological Assay; Blood Platelets; Clofibrate; Glycerol; Indomethacin; Inflammation; Phenylbutazone; Platelet Adhesiveness; Prostaglandins; Tissue Extracts; Vasoconstrictor Agents | 1973 |
Structure of hepatic microbodies in rats treated with acetylsalicylic acid, clofibrate, and dimethrin.
Topics: Animals; Aspirin; Benzyl Compounds; Body Weight; Carboxylic Acids; Cholesterol; Chrysanthemum cinerariifolium; Clofibrate; Cyclopropanes; Endoplasmic Reticulum; Hepatomegaly; Histocytochemistry; Liver; Male; Microbodies; Organ Size; Organoids; Rats; Triglycerides | 1974 |
[Studies of the interactions of clofibrate with the reproductive function].
Topics: 17-Ketosteroids; Animals; Animals, Newborn; Aspirin; Clofibrate; Estrogens; Estrus; Female; Fertility; Gonads; Male; Organ Size; Pregnancy; Rats | 1974 |
[Pathologic and therapeutic similarities between arteriosclerosis and lithiasic cholecystitis].
Topics: Acetamides; Aminosalicylic Acids; Animals; Arteriosclerosis; Aspirin; Cholecystitis; Cholelithiasis; Cholesterol; Cholestyramine Resin; Clofibrate; Diagnosis, Differential; Humans; Lipids; Mice; Thyroxine; Vitamin E | 1971 |
[Experimental therapy of gallbladder lithiasis. Preventive and curative effects of various drugs in mice].
Topics: Animals; Aspirin; Cholelithiasis; Cholestyramine Resin; Clofibrate; Dehydrocholic Acid; Hydantoins; Mice; Sodium Salicylate; Thyroxine | 1970 |
Induction of a novel long-chain acyl-CoA hydrolase in rat liver by administration of peroxisome proliferators.
Topics: Animals; Aspirin; Clofibrate; Diethylhexyl Phthalate; Electrophoresis, Polyacrylamide Gel; Enzyme Induction; Liver; Male; Molecular Weight; Octoxynol; Palmitoyl-CoA Hydrolase; Phthalic Acids; Polyethylene Glycols; Rats; Serum Albumin, Bovine; Thiolester Hydrolases | 1981 |
[Evaluation of the effects of plafibride and lysine acetyl salicylate on the production of PGI2].
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Clofibrate; Clofibric Acid; Diet, Atherogenic; Epoprostenol; Lysine; Male; Platelet Aggregation; Rabbits | 1983 |
Hydrolysis of ester- and amide-type drugs by the purified isoenzymes of nonspecific carboxylesterase from rat liver.
Topics: Amides; Animals; Arecoline; Aspirin; Carboxylesterase; Carboxylic Acids; Carboxylic Ester Hydrolases; Choline; Clofibrate; Esters; Hydrolysis; In Vitro Techniques; Isoenzymes; Kinetics; Microsomes, Liver; Procaine; Propanidid; Rats | 1984 |
Selective increase in acylation of 1-acylglycerophosphorylcholine in livers of rats and mice by peroxisome proliferators.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acylation; Acyltransferases; Animals; Aspirin; Clofibrate; Clofibric Acid; Fatty Alcohols; Glycerylphosphorylcholine; Guinea Pigs; Hypolipidemic Agents; Liver; Lysophosphatidylcholines; Male; Mice; Microbodies; Microsomes, Liver; Rats; Rats, Inbred Strains | 1984 |
Effects of antirheumatoid drugs on the production and action of porcine catabolin.
Topics: Animals; Aspirin; Cartilage; Cattle; Chloroquine; Chondroitin Sulfates; Clofibrate; Culture Techniques; Dose-Response Relationship, Drug; Glycine; Gold Sodium Thiomalate; Interleukin-1; Interleukin-1beta; Penicillamine; Prednisolone; Protein Biosynthesis; Swine; Synovial Membrane | 1982 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Nicotinic Acids; Sitosterols; Sulfinpyrazone | 1980 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators.
Topics: Acyl Coenzyme A; Amitrole; Animals; Aspirin; Caprylates; Catalase; Clofibrate; Decanoic Acids; Diet; Fluorocarbons; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Lipid Peroxidation; Liver; Mice; Mice, Inbred C57BL; Microbodies; Microsomes, Liver; Mitochondria, Liver; NAD(P)H Dehydrogenase (Quinone); Nafenopin; Oxidation-Reduction; Oxidative Stress; Palmitoyl Coenzyme A; Superoxide Dismutase; Ubiquinone; Vitamin E | 1995 |
Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
Topics: Acetyl-CoA C-Acetyltransferase; Acyl-CoA Oxidase; Animals; Anti-Inflammatory Agents; Aspirin; Base Sequence; Brain; Catalase; Clofibrate; Diflunisal; Hypolipidemic Agents; Lipid Peroxidation; Liver; Male; Microbodies; Molecular Sequence Data; Oxidative Stress; Oxidoreductases; Probucol; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Zinc | 1994 |
Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid, and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis.
Topics: Animals; Aspirin; Caprylates; Clofibrate; Cytochromes c1; Fluorocarbons; Malate Dehydrogenase; Male; Membrane Proteins; Microbodies; Mitochondria; Mitochondrial ADP, ATP Translocases; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Ribosomal, 16S; Thyroid Hormones | 1996 |
Effects of peroxisome proliferators and/or hypothyroidism on xenobiotic-metabolizing enzymes in rat testis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arylsulfotransferase; Aspirin; Caprylates; Catalase; Clofibrate; Diet; Diethylhexyl Phthalate; Disease Models, Animal; Epoxide Hydrolases; Fluorocarbons; Glucuronosyltransferase; Glutathione Peroxidase; Glutathione Transferase; Hypolipidemic Agents; Hypothyroidism; Male; Microbodies; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Sprague-Dawley; Testis | 1997 |
Induction of endogenous coenzyme Q biosynthesis by administration of peroxisomal inducers.
Topics: Aging; Animals; Aspirin; Clofibrate; Dehydroepiandrosterone; Diethylhexyl Phthalate; Intracellular Membranes; Liver; Male; Microbodies; Mitochondria, Liver; Organ Specificity; Organelles; Peroxisome Proliferators; Rats; Rats, Sprague-Dawley; Ubiquinone | 1999 |
Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Chemokine CCL2; Clofibrate; Dose-Response Relationship, Drug; Endothelial Cells; Fenofibrate; Gene Expression Regulation; Glucose; Humans; NADPH Oxidases; NF-kappa B; Onium Compounds; Peroxisome Proliferators; PPAR alpha; Proto-Oncogene Proteins c-jun; Reactive Oxygen Species; Tosylphenylalanyl Chloromethyl Ketone; Transcription Factor RelA | 2006 |